These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction. Kahn B; Borrelli M; Libby T J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044 [TBL] [Abstract][Full Text] [Related]
7. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675 [TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Belenky P; Racette FG; Bogan KL; McClure JM; Smith JS; Brenner C Cell; 2007 May; 129(3):473-84. PubMed ID: 17482543 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117 [TBL] [Abstract][Full Text] [Related]
10. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638 [TBL] [Abstract][Full Text] [Related]
11. NAD Yoshino J; Baur JA; Imai SI Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689 [TBL] [Abstract][Full Text] [Related]
12. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease. Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144 [TBL] [Abstract][Full Text] [Related]
13. Elevation of NAD Metcalfe M; David BT; Langley BC; Hill CE Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712 [TBL] [Abstract][Full Text] [Related]
14. Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells. Kulikova V; Shabalin K; Nerinovski K; Dölle C; Niere M; Yakimov A; Redpath P; Khodorkovskiy M; Migaud ME; Ziegler M; Nikiforov A J Biol Chem; 2015 Nov; 290(45):27124-27137. PubMed ID: 26385918 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise. Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681 [TBL] [Abstract][Full Text] [Related]
17. Balancing NAD Cercillieux A; Ciarlo E; Canto C Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544 [TBL] [Abstract][Full Text] [Related]
18. Dihydronicotinamide riboside is a potent NAD Yang Y; Mohammed FS; Zhang N; Sauve AA J Biol Chem; 2019 Jun; 294(23):9295-9307. PubMed ID: 30948509 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD Ciarlo E; Joffraud M; Hayat F; Giner MP; Giroud-Gerbetant J; Sanchez-Garcia JL; Rumpler M; Moco S; Migaud ME; Cantó C Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807932 [TBL] [Abstract][Full Text] [Related]
20. The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma. Goulart Nacácio E Silva S; Occhiutto ML; Costa VP Eur J Ophthalmol; 2023 Sep; 33(5):1801-1815. PubMed ID: 36916064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]